Research at MD Anderson has daily impact on our patients. They come from all over the world, with every form of lung cancer. They benefit from the latest therapies, delivered by experts known for advancing their fields.
In our Lung Cancer Moon Shot, we’re profiling tumors to find cancer-driving mutations and choose the best therapies aimed at those alterations. We’re combining biomarkers and CT imaging to improve lung cancer screening. And we’re using new strategies to stop smoking — lung cancer’s top cause — and prevent kids from starting.
New knowledge and progress-enabling technologies make this the time to reduce cancer deaths. MD Anderson's comprehensive Moon Shots Program capitalizes on these novel resources as it builds on a 70-plus-year history of renowned expertise, lifesaving innovation and global impact.Learn more
Finding new uses for existing therapies can shave years and millions of dollars from the cancer drug development process. MD Anderson lung researchers are collaborating with our Institute for Applied Cancer Science to channel drugs used in other malignancies against mutations shared in common with lung cancer.